Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: Will new dialysis solutions prevent these changes?

International Urology and Nephrology

Volumn 37, Issue 2, 2005, Pages 409-418

  Krishnan, Murali ^a   Tam, Paul ^b   Wu, George ^c   Breborowicz, Andrzej ^d   Oreopoulos, Dimitrios G ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b SCARBOROUGH HOSPITAL   (Canada)

^c Institute of Kidney Lifescience Technologies   (Canada)

^d CREDIT VALLEY HOSPITAL   (Canada)

Author keywords

Biocompatibility; Glucose degradation products; Peritoneal dialysis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CELL RECEPTOR; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; OSMOTIC AGENT; PERITONEAL DIALYSIS FLUID;

ARTICLE; BIOCOMPATIBILITY; BLOOD VESSEL WALL; CELL FUNCTION; CELL STRUCTURE; CORRELATION ANALYSIS; DIABETES MELLITUS; ENDOTHELIUM CELL; HEAT TREATMENT; HUMAN; INFECTION RATE; INSTRUMENT STERILIZATION; LONG TERM CARE; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEUM CELL; PERITONITIS; SMOOTH MUSCLE FIBER; TISSUE INJURY; TREATMENT FAILURE; ULTRAFILTRATION;

ANIMALS; GLUCOSE; HEMODIALYSIS SOLUTIONS; HUMANS; PERITONEAL DIALYSIS; PERITONEUM;

EID: 25144466012     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-004-1392-1     Document Type: Article

References (62)

1. JD Williams KJ Craig C Rhuland von et al. 2003 for the Biopsy Registry Study Group. The natural course of peritoneal membrane biology during peritoneal dialysis Kidney Int 64 (suppl. 88) S43-S49 10.1046/ j.1523-1755.2003.08805.x
2. MJ Beavis JL Harwood GA Coles JD. Williams 1994 Synthesis of phospholipids by human peritoneal mesothelial cells Perit Dial Int 14 348-355 7827184
3. JW Dobbie T Pavlina J Lloyd RC. Johnson 1988 Phosphatidylcholine synthesis by peritoneal mesothelium: Its implication for peritoneal dialysis Am J Kidney Dis 12 31-36 3389351
4. N Topley A Jorres W Luttmann 1993 Human peritoneal mesothelial cells synthesize IL-6: Induction by IL-1b and TNF alpha Kidney Int 43 226-233 8433563
5. MJ Beavis JD Williams J Hoppe N. Topley 1997 Human peritoneal fibroblast proliferation in 3-dimensional culture: Modulation by cytokines, growth factors and peritoneal dialysis effluent Kidney Int 51 205-215 8995735
6. JW Dobbie JK Lloyd CA. Gall 1990 Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients Adv Perit Dial 6 3-12 1982832
7. JW. Dobbie 1993 Peritoneal ultrastructure and changes with continuous ambulatory peritoneal dialysis Perit Dial Int 13 S585-S587 8399672
8. N Topley JJ Craig M Fallon et al. 1999 Morphological changes to the peritoneal membrane of patients on peritoneal dialysis (PD) are related to time on treatment J Am Soc Nephrol 10 324A
9. K Honda K Nitta H Horita et al. 1996 Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure Nephron 72 171-176 8684522
10. MF. Flessner 1996 Small solute transport across specific peritoneal tissue surfaces in the rat J Am Soc Nephrol 7 225-233 8785391
11. KJ Craig N Topley GT Williams JD. Williams 2001 Morphological changes in the peritoneal membrane of patients on peritoneal dialysis (PD) correlate with total glucose exposure and peritonitis rates J Am Soc Nephrol 12 297-308 11158219
12. Feriani M. Buffers. 1996 Bicarbonate, lactate and pyruvate Kidney Int 50 56 S75
13. Frohlich ED 1965 Vascular effects of the Krebs intermediate metabolites Am J Physiol 208 149-156 14253139
14. S Mortier AS De vriese J Van de Voorde 2002 Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, glucose degradation products J Am Soc Nephrol 13 480-489 11805178
15. B Musi O Carlsson A Rippe et al. 1998 Effects of acidity, glucose degradation products and dialysis buffer choice on peritoneal solute and fluid transport in rats Perit Dial Int 18 303-310 9663895
16. GP Grodstein MJ Blumenkrantz JD Kopple et al. 1981 Glucose absorption during continuous ambulatory peritoneal dialysis Kidney Int 19 564-567 7241890
17. VW Amstrong W Creutzfeldt R Ebert et al. 1985 Effect of dialysis glucose load on plasma and glucoregulatory hormones in CAPD patients Nephron 39 141-145 3883205
18. R Khanna WC Breckenridge DAK Roncari et al. 1983 Lipids abnormalities in patients undergoing continuous ambulatory peritoneal dialysis Perit Dial Bull 3 S13-S15
19. M. Pischetsrieder 2000 Chemistry of glucose and biochemical pathways of biological interest Perit Dial Int 20 2 S26-S30 10911639
20. IS Henderson LA Couper A Lumsden JF. Maher 1986 Potentially irritant glucose metabolites in unused CAPD fluid In: JF Wincester ed. Frontiers in Peritoneal Dialysis Field, Rich and Associates, Inc Newyork 261-264
21. AP Wieslander MK Nordin PT Kjellstrand UC. Boberg 1991 Toxicity of peritoneal dialysis fluid on cultured fibroblasts, L-929 Kidney Int 40 77-79 1921158
22. J Witowski A Jorres K Korybalska et al. 2003 Glucose degradation products in peritoneal dialysis fluids: Do they harm? Kidney Int 63 84 S148-S151 10.1046/j.1523-1755.63.s84.18.x
23. CB Nilsson-Thorell N Muscalu AH Andren et al. 1993 Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes Perit Dial Int 13 208-213
24. S Yung M. Davies 1998 Response of the human peritoneal mesothelial cell to injury: An in-vitro model for peritoneal wound healing Kidney Int 54 2160-2169 10.1046/j.1523-1755.1998.00177.x 9853283
25. AP Wieslander AH Andren C Nilsson-Thorell et al. 1995 Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro? Perit Dial Int 15 348-352 8785233
26. K Witowski J Korybalska J Wiesniewska et al. 2000 Effect of glucose degradation products on human peritoneal mesothelial cell function J Am Soc Nephrol 11 729-739 10752532
27. A Jorres J Witowski K Korybalska et al. 1998 Effect of glucose degradation products on human peritoneal mesothelial cell (HPMC) proliferation and Interleukin (IL)-6 production Perit Dial Int 18 113A
28. LW Morgan A Wieslander M Davies et al. 2003 Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration Kidney Int 64 1854-1866 10.1046/j.1523-1755.2003.00265.x 14531821
29. A Weislander T Linden B Musi et al. 2000 Biological significance of reducing glucose degradation products in peritoneal dialysis fluids Perit Dial Int 20 suppl. 5 S23-S27 11229608
30. M Tuncer M Sarikaya T Sezer et al. 2000 Chemical peritonitis associated with high dialysate acetaldehyde concentrations Nephrol Dial Transplant 15 2037-2040 10.1093/ndt/15.12.2037 11096151
31. A Weislander T Linden P. Kjellstrand 2001 Glucose degradation products in peritoneal dialysis fluids: How can they be avoided Perit Dial Int 21 suppl. 3 S119-S124 11887805
32. T Linden G Forsback R Deppisch et al. 1998 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis Perit Dial Int 18 290-293 9663893
33. CG Schalkwijk N Posthuma HJ ten Brink et al. 1999 Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids Perit Dial Int 19 325-333
34. JH Lee DK Reddy R Saran et al. 2000 Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with Icodextrin Perit Dial Int 20 suppl. 5 S39-S47 11229611
35. M Nakayama H Kubo A Ogawa et al. 1997 Immunohistochemical detection of advanced glycation end products (AGEs) in the peritoneum and its possible pathophysiological role in CAPD Kidney Int 51 182-186 8995732
36. RT Krediet MM Zweers AC Wal van der DG. Struijk 2000 Neoangiogenesis in the peritoneal membrane Perit Dial Int 20 suppl. 2 S19-S25
37. A Weislander T Linden B Musi et al. 1991 Biological significance of reducing glucose degradation products in peritoneal dialysis fluids Perit Dial Int 20 suppl. 5 S23-S27
38. M Zeier V Schwenger R Deppisch et al. 2003 Glucose degradation products in PD fluids: Do they disappear from the systemic circulation? Kidney Int 63 298-305 10.1046/j.1523-1755.2003.00705.x 12472796
39. Z Makita R Bucala EJ Rayfield et al. 1994 Reactive glycose-lation end-products in diabetic uremia and treatment of renal failure Lancet 343 1519-1522 10.1016/S0140-6736(94)92935-1 7911868
40. LA Cooker P Luneburg CJ Holmes et al. 2001 on behalf of the Bicarbonate/ Lactate Study Group. Interleukin-6 levels in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions Perit Dial Int 21 suppl. 3 S102-S107 11887802
41. R Pecoits-Filho MJ Carvalho S-H Chung et al. 2002 Interleukin-6 (IL-6) system and peritoneal solute transport rate: A longitudinal study J Am Soc Nephrol 13 42A 10.1159/000049149
42. AB Dawnay DJ. Millar 1997 Glycation and advanced glycation end-product formation with icodextrin and dextrose Perit Dial Int 17 52-58 9068023
43. I Lebedo A Weislander P. Kjellstrand 2000 Can we prevent degradation of glucose in peritoneal dialysis solutions? Perit Dial Int 20 suppl. 2 S48-S51
44. J Passlick-Deetjen C. Lage 2000 Lactate-buffered and bicarbonate-buffered solutions with less glucose degradation products in a two-chamber system Perit Dial Int 20 suppl. 2 S42-S47 10911642
45. C Lage M Pischetsrieder C Aufricht et al. 2000 First in vitro and in vivo experiences with Stay.Safe Balance, A pH-neutral solution in a dual-chambered bag Perit Dial Int 20 suppl. 5 S28-S32 11229609
46. J Witowski K Korybalska K Ksiazek et al. 2004 Peritoneal Dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells Nephrol dial transplant 19 917-924 10.1093/ndt/gfh013 15031350
47. B Rippe O Simonsen O Heimburger et al. 2001 Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products Kidney Int 59 348-357 10.1046/j.1523-1755.2001.00497.x 11135090
48. G Capelli G Bandani Cancarini GC et al. 1999 Low concentrations of glucose degradation products in peritoneal dialysis fluids and their impact on biocompatibility parameters: Prospective cross-over study with a three-compartment bag Adv PD 15 238-242
49. M Feriani J Kirchgessner G La Greca J Passlick-Deetjenthe The Bicarbonate CAPD Cooperative Group. 1998 Randomized long-term evaluation of bicarbonate-buffered CAPD solution Kidney Int 54 1731-1738 10.1046/ j.1523-1755.1998.00167.x 9844152
50. J Plum P Razeghi RM Lordnejad et al. 2001 Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells Am J Kidney Dis 38 867-875 11576893
51. MS Park JK Kim C Holmes MF. Weiss 2000 Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation Perit Dial Int 20 5 S33-S38 11229610
52. RA Mactier TS Sprosen R Gokal et al. 1998 Bicarbonate and bicarbonate/ lactate peritoneal dialysis solutions for the treatment of infusion pain Kidney Int 53 1061-1067 10.1111/j.1523-1755.1998.00849.x 9551418
53. M Dratwa M Wilkie J-P Ryckelynck et al. 2003 on behalf of the Physioneal APD Research Group. Clinical experience with two physiologic bicarbonate/ lactate peritoneal dialysis solutions in automated peritoneal dialysis Kidney Int 64 suppl. 88 S105-S113 10.1046/j.1523-1755.2003.08812.x
54. A. Tranaeus 2000 A long-term study of bicarbonate/lactate-based peritoneal dialysis solution-clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 20 516-523
55. M Van Bree D Miserque KO Story et al. 2002 J Am Soc Nephrol 13 S43A
56. le Poole C, Weijmer M, van Ittersum F et al. Clinical Effects of a PD Regimen Low in Glucose and GDP's (LG) Compared to a Standard PD Regimen (SPD) in Newly CAPD Patients. J Am Soc Nephrol 2002 (suppl. abs): 200A.
57. Williams JD, Craig KJ, Passlick-Deetjen J et al. for the Euro Balance Trial Group. Reduced Systemic AGE Formation with a Low GDP Solution (CAPD Balance): Data from the Multicentre Europoean Balance Trial.
58. ZH Zheng F Sederholm B Anderstam et al. 2001 Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats Kidney Int 60 2392-2398 10.1046/j.1523-1755.2001.00075.x 11737615
59. Haag-Weber M, Hauyou U, Wieslander A et al. And the DIUREST Study Group: decline of residual renal function in peritoneal dialysis patients depends on uptake of carbonyl compounds from the peritoneal cavity: First data of a prospective clinical trial. J Am Soc Nephrol 14, 2003: 476A
60. JD Willams N Topley KJ Craig et al. 2004 The euro-balance trial: The effect of a new biocompatible peritoneal dialysis fluid (Balance) on the peritoneal membrane Kidney Int. 66 408-418 10.1111/ j.1523-1755.2004.00747.x 15200450
61. R Inagi T Miyata Y Ueda et al. 2002 Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid Kidney Int 62 679-687 10.1046/ j.1523-1755.2002.00488.x 12110033
62. Ishikawa Naoyoshi Miyata Toshio Ueda Yasuhiko 2003 Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid Kidney Int 63 331-339 10.1046/ j.1523-1755.2003.00732.x 12472800